Kancera AB

At a glance

Most recent filing on April 12, 2024 — a grant by Peter Selin on Apr 12, 2024.

We hold 5 visible filings, going back to February 26, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

All 5 shown

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Peter Selin Chief executive officer
255,414 SEKGrant
TradedApr 12, 2024FiledApr 12, 2024
Erik Nerpin Chair of the board
113,000 sharesAdministrative
TradedFeb 15, 2021FiledFeb 15, 2021
Thomas Olin CEO
46,184 SEKOpen-market buy
TradedSep 30, 2020FiledOct 1, 2020
Johan Mikael Schultz Projektdirektör
41,075 SEKOpen-market sale
TradedSep 21, 2020FiledSep 21, 2020
Joachim Forsgren Chief medical officer
115,000 SEKOpen-market buy
TradedFeb 26, 2019FiledFeb 26, 2019